New sights of low dose IL‐2: Restoration of immune homeostasis for viral infection

Abstract Viral infection poses a significant threat to human health. In addition to the damage caused by viral replication, the immune response it triggers often leads to more serious adverse consequences. After the occurrence of viral infection, in addition to the adverse consequences of infection, chronic infections can also lead to virus‐related autoimmune diseases and tumours. At the same time, the immune response triggered by viral infection is complex, and dysregulated immune response may lead to the occurrence of immune pathology and macrophage activation syndrome. In addition, it may cause secondary immune suppression, especially in patients with compromised immune system, which could lead to the occurrence of secondary infections by other pathogens. This can often result in more severe clinical outcomes. Therefore, regarding the treatment of viral infections, restoring the balance of the immune system is crucial in addition to specific antiviral medications. In recent years, scientists have made an interesting finding that low dose IL‐2 (ld‐IL‐2) could potentially have a crucial function in regulating the immune system and reducing the chances of infection, especially viral infection. Ld‐IL‐2 exerts immune regulatory effects in different types of viral infections by modulating CD4 + T subsets, CD8 + T cells, natural killer cells, and so on. Our review summarised the role of IL‐2 or IL‐2 complexes in viral infections. Ld‐IL‐2 may be an effective strategy for enhancing host antiviral immunity and preventing infection from becoming chronic; additionally, the appropriate use of it can help prevent excessive inflammatory response after infection. In the long term, it may reduce the occurrence of infection‐related autoimmune diseases and tumours by promoting the restoration of early immune homeostasis. Furthermore, we have also summarised the application of ld‐IL‐2 in the context of autoimmune diseases combined with viral infections; it may be a safe and effective strategy for restoring immune homeostasis without compromising the antiviral immune response. In conclusion, focusing on the role of ld‐IL‐2 in viral infections may provide a new perspective for regulating immune responses following viral infections and improving prognosis.